More on MGX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.20 |
|
|||
| Open | $1.22 | ||||
| 52 Wk High | $0.65 | ||||
| 52 Wk Low | $0.65 | ||||
| Day High | $1.26 | ||||
| Day Low | $1.20 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 303,195 | ||||
- Metagenomi Inc (MGX) PT Lowered to $7 at Wells Fargo
- Metagenomi, Inc. (MGX) Tops Q2 EPS by 5c
- Form 10-Q Metagenomi Therapeutics, For: Jun 30
- Form 8-K Metagenomi Therapeutics, For: Aug 10
- Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
- Prolynx names CFO and CSO to advance obesity drug portfolio
- Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio
- Chardan Starts Metagenomi Inc (MGX) at Buy
- Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: Reid Laurence
- Form 4 Metagenomi Therapeutics, For: Jun 09 Filed by: Dere Willard H
Entities mentioned with MGX
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Cowen & Co | View Related Stories »
- Chardan Capital Markets | View Related Stories »
- Show More...
